"10.1371_journal.pone.0041834","plos one","2012-07-25T00:00:00Z","Qinlong Liu; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Charles D Smith; Zhi Zhong","Departments of Pharmaceutical & Biomedical Sciences and Medical University of South Carolina, Charleston, South Carolina, United States of America; Biochemistry & Molecular Biology, and Medical University of South Carolina, Charleston, South Carolina, United States of America; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, United States of America; Apogee Biotechnology Corporation, Hummelstown, Pennsylvania, United States of America","Conceived and designed the experiments: ZZ CDS. Performed the experiments: QL HR YS YK. Analyzed the data: QL HR ZZ. Contributed reagents/materials/analysis tools: CDS ZZ JJL. Wrote the paper: ZZ CDS JJL.","CDS, one of the coauthors, is the founder and president of Apogee Biotechnology Corporation which synthesized ABC294640 for this study. The authors are in the process of filing a patent application on using this sphingosine kinase inhibitor in ischemia/reperfusion injury (Treatment Of Ischemia-Reperfusion Injury. Case No.: 09-486-WO-US). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","07","Qinlong Liu","QL",7,TRUE,2,4,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
